Live bacteria cream shows promise for rare skin disease
Disease control
Completed
This early-stage trial tests a cream called ATR12-351 for Netherton syndrome, a rare genetic skin condition. The cream contains live bacteria that produce a protein missing in people with the disease. Twelve adults will apply the cream to one side of their body and a placebo to t…
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC